Perpetuals.com Ltd. (NASDAQ: PDC) has announced the expansion of its BayesShield artificial intelligence technology into the healthcare sector with the launch of BayesShield Clinical. The new platform is designed to identify physicians with the strongest diagnostic accuracy across specific case types, applying the company’s statistical methodology originally developed for financial markets to reduce bias and improve clinical decision-making.
The initial deployment of the healthcare platform will be supported through a partnership with the European Institute of Management, which will oversee pilot programs and academic validation of the technology. This represents a significant expansion for the fintech company, which has traditionally focused on AI-powered trading products and prediction markets with a global footprint across the United States, Europe, and Asia.
The company’s proprietary trading platform, Kronos X, combines advanced AI and data analysis, trained on billions of trades to monitor market activity in real time, identify patterns for trading and risk decisions, and provide multi-asset coverage with self-clearing blockchain-based settlement. The licensed European Multilateral Trading Facility infrastructure and Kronos X multi-asset exchange platform operate with full regulatory compliance including MiFID II, MiCA, DORA, and EMIR requirements.
According to the company’s announcement, the expansion into healthcare represents a broader application of its AI methodology to decision-intensive domains beyond finance. The move comes as artificial intelligence applications in healthcare continue to grow, with technologies aimed at improving diagnostic accuracy and reducing human bias in medical decision-making processes.
Additional information about the company and its developments is available through its newsroom at https://ibn.fm/PDC. The company’s CEO, Patrick Gruhn, is a professor and PhD candidate in computer science and engineering, and founder of the Patrick Gruhn Institute at the European Institute of Management, which is now partnering with the company on the healthcare initiative.
The announcement was distributed through AINewsWire, a specialized communications platform focused on artificial intelligence advancements, which is part of the Dynamic Brand Portfolio that includes more than 75 brands. AINewsWire provides distribution services including access to wire solutions, article syndication to over 5,000 outlets, press release enhancement, social media distribution, and corporate communications solutions.
This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Perpetuals.com Expands AI Technology from Finance to Healthcare with New Clinical Diagnostic Platform.